Skip to content

Analgesic Effect of Levobupivacaine in Breast Augmentation

Analgesic Efficacy of Levobupivacaine Administration in Periprosthetic Breast Augmentation With Implants

Status
Suspended
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02465008
Enrollment
66
Registered
2015-06-08
Start date
Unknown
Completion date
2016-07-31
Last updated
2016-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

postoperative, Patient-reported

Brief summary

The purpose of this study is to determine whether levobupivacaine is effective in the acute postoperative pain treatment in periprosthetic breast augmentation

Detailed description

One of the most common plastic surgery is breast augmentation using prosthesis ( mammoplasty Surgery with cohesive silicone gel prosthesis insubpectoral plane). Remains challenging management of acute postoperative pain that allows for early discharge of patients. To this end the following objectives are proposed: evaluate the analgesic efficacy of L-Bupivacaine 0.25% vs. Placebo (saline) administered irrigation into the surgical pocket bilaterally intraoperatively.

Interventions

DRUGLevobupivacaine
DRUGPlacebo

Sponsors

General University Hospital of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Women\> 18 and \<= 65 years * Mammoplasty Surgery with cohesive silicone gel prosthesis in subpectoral plane * ASA I and II * Informed consent signed

Exclusion criteria

* Rejection of the patient * ASA III or higher * Other conditions that warrant their inclusion as medically indicated (eg psychiatric illness). * Allergy to NSAIDs, local anesthetics and / or morphine * Patients treated for chronic pain * Placement of drains for surgical needs

Design outcomes

Primary

MeasureTime frame
Patient-reported postoperative pain. evaluated by a Visual Analog Scale (VAS) at rest and movement (cough).at 6 hours the early postoperative period (after the end of anesthesia)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026